Table 2.
Changes of interventions of OBPE between 2016 and 2022 in the tertiary hospital.
| Item | Baseline survey (Nb = 781) | Follow up survey (Nf = 1559) | ||
|---|---|---|---|---|
| n | % | n | % | |
| Occupational health training | ||||
| Pre-employment training*** | 490 | 62.74 | 1357 | 87.04 |
| On-the-job training*** | 684 | 87.58 | 1519 | 97.43 |
| OBPE training*** | 666 | 85.28 | 1482 | 92.68 |
| Immune status | ||||
| Hepatitis B vaccination status*** | 626 | 80.15 | 1118 | 71.71 |
| Positive for HBsAb *** | 428 | 54.80 | 619 | 39.70 |
| Awareness in HBsAb status*** | 557 | 71.32 | 905 | 58.05 |
| Accuracy of OBPE knowledge | ||||
| Hierarchy of occupational risk control | 40 | 5.12 | 87 | 5.58 |
| Immediately transfer from the post after OBPE*** | 489 | 62.61 | 643 | 41.24 |
| Reduction of unnecessary injections*** | 548 | 70.17 | 1250 | 80.18 |
| Emergency response measures after OBPE | 30 | 3.84 | 85 | 5.45 |
| PEP for HIV** | 746 | 95.52 | 1519 | 97.43 |
| Mucous membrane, nonintact skin exposure risk | 776 | 99.36 | 915 | 97.97 |
*** indicates p < 0.001; ** indicates p < 0.01; PEP, Post-exposure prophylaxis; the exposure period in baseline survey from July 1, 2015 to June 30, 2016; the exposure period in follow up survey is from July 1, 2021 to June 30, 2022. The bold values mean the date of indicators <10% which need to be paid attention urgently.